These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Loss of body hair as a side effect of albendazole. Tas A; Köklü S; Celik H Wien Klin Wochenschr; 2012 Mar; 124(5-6):220. PubMed ID: 22198117 [No Abstract] [Full Text] [Related]
4. Acute drug-induced hepatitis caused by albendazole. Choi GY; Yang HW; Cho SH; Kang DW; Go H; Lee WC; Lee YJ; Jung SH; Kim AN; Cha SW J Korean Med Sci; 2008 Oct; 23(5):903-5. PubMed ID: 18955802 [TBL] [Abstract][Full Text] [Related]
5. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita. Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585 [TBL] [Abstract][Full Text] [Related]
6. Albendazole-induced toxic hepatitis: A case report. Gözüküçük R; Abci İ; Güçlü M Turk J Gastroenterol; 2013; 24(1):82-4. PubMed ID: 23794356 [No Abstract] [Full Text] [Related]
7. Anagen effluvium and the role of trichoscopy. Starace M; Orlando G; Bruni F; Alessandrini A; Piraccini BM Clin Exp Dermatol; 2022 Mar; 47(3):589-591. PubMed ID: 34642956 [No Abstract] [Full Text] [Related]
8. Anagen effluvium secondary to Bains A; Verma GK; Vedant D; Negi A Indian J Dermatol Venereol Leprol; 2016; 82(6):677-680. PubMed ID: 27451928 [TBL] [Abstract][Full Text] [Related]
10. Telogen effluvium after oral albendazole. Veraldi S; Francia C; La Vela V; Nazzaro G; Barbareschi M Clin Exp Dermatol; 2012 Jul; 37(5):565-7. PubMed ID: 22420487 [No Abstract] [Full Text] [Related]
11. Fixed drug eruption with albendazole and it's cross-sensitivity with metronidazole--a case report. Mahboob A; Haroon TS J Pak Med Assoc; 1998 Oct; 48(10):316-7. PubMed ID: 10087757 [No Abstract] [Full Text] [Related]
12. Circumscribed alopecia areata incognita. Park J; Song KH; Nam KH Australas J Dermatol; 2013 Feb; 54(1):52-4. PubMed ID: 22671761 [TBL] [Abstract][Full Text] [Related]
13. Drug-induced psychosis associated with albendazole-ivermectin combination therapy. Sinha P; Garg A; Prakash O; Desai NG Gen Hosp Psychiatry; 2012; 34(5):578.e9-578.e10. PubMed ID: 22325629 [TBL] [Abstract][Full Text] [Related]
14. Telogen effluvium associated with albendazole therapy. Pilar García-Muret M; Sitjas D; Tuneu L; de Moragas JM Int J Dermatol; 1990 Nov; 29(9):669-70. PubMed ID: 2272743 [No Abstract] [Full Text] [Related]
15. Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran. Alizadeh A; Ranjbar M; Kashani KM; Taheri MM; Bodaghi M East Mediterr Health J; 2006 Sep; 12(5):548-54. PubMed ID: 17333792 [TBL] [Abstract][Full Text] [Related]
16. Azathioprine-Induced Anagen Effluvium with Myelosuppression. Prabha N; Khare S Skinmed; 2022; 20(3):192-196. PubMed ID: 35779024 [TBL] [Abstract][Full Text] [Related]
17. Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis. Escobedo AA; Núñez FA; Moreira I; Vega E; Pareja A; Almirall P Ann Trop Med Parasitol; 2003 Jun; 97(4):367-71. PubMed ID: 12831522 [TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical and histologic correlations in alopecia areata and telogen effluvium: adversities in alopecia pattern mimicry. Rashid RM Cutis; 2013 Mar; 91(3):141-4. PubMed ID: 23617085 [No Abstract] [Full Text] [Related]
20. Adverse events associated with albendazole and other products used for treatment of giardiasis in dogs. Meyer EK J Am Vet Med Assoc; 1998 Jul; 213(1):44-6. PubMed ID: 9656022 [No Abstract] [Full Text] [Related] [Next] [New Search]